Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized early treatment regimens for high-risk acute pancreatitis
ChiCTR-IPR-14005518Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of gabexate and octreotide in acute pancreatitis (AP) (8 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Incidence of progression from mild acute pancreatitis to moderately severe acute pancreatitis and Incidence of progression from moderately severe acute pancreatitis to severe acute pancreatitis. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
gabexateoctreotide
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-IPR-14005518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005518.